MedPath

WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE

WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE

Dormant
DIN Number

02453703

Drug Class

Human

Market Date

Dec 23, 2016

Company
HC

Jamp Pharma Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02453703
AIG Number0311391002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02BE51 ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.92
Health Canada Classification

ACTIVE INGREDIENTS (3)

ACETAMINOPHENActive
Strength: 300 MG
Monograph: ACETAMINOPHEN
CAFFEINEActive
Strength: 15 MG
Monograph: CAFFEINE
CODEINE PHOSPHATEActive
Strength: 8 MG
Monograph: CODEINE PHOSPHATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.